Abstract
The COVID-19 pandemic is shining a spotlight on the field of immunology like never before. To appreciate the diverse ways in which immunologists have contributed, Nature Reviews Immunology invited the president of the International Union of Immunological Societies and the presidents of 15 other national immunology societies to discuss how they and their members responded following the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Antiviral Agents / chemical synthesis
-
Antiviral Agents / therapeutic use
-
Betacoronavirus / drug effects
-
Betacoronavirus / immunology
-
Betacoronavirus / pathogenicity
-
COVID-19 / epidemiology*
-
COVID-19 / immunology
-
COVID-19 / prevention & control
-
COVID-19 / therapy
-
COVID-19 Vaccines
-
Community-Institutional Relations
-
Coronavirus Infections / epidemiology*
-
Coronavirus Infections / immunology
-
Coronavirus Infections / prevention & control
-
Coronavirus Infections / therapy
-
Global Health / trends
-
Humans
-
International Cooperation*
-
Pandemics*
-
Patient Education as Topic / organization & administration
-
Personal Protective Equipment / supply & distribution
-
Pneumonia, Viral / epidemiology*
-
Pneumonia, Viral / immunology
-
Pneumonia, Viral / therapy
-
SARS-CoV-2
-
Severe Acute Respiratory Syndrome / epidemiology*
-
Severe Acute Respiratory Syndrome / immunology
-
Severe Acute Respiratory Syndrome / therapy
-
Societies, Scientific / organization & administration*
-
Viral Vaccines / biosynthesis
Substances
-
Antiviral Agents
-
COVID-19 Vaccines
-
Viral Vaccines